Confident Investing Starts With TipRanks Premium

Get 55% Off
TipRanks
Go Ultimate55% OFF

Cencora (COR) Stock Price & Analysis

COR Stock Chart & Stats

$333.59$2.75(0.83%)
At close: 11:25 AM EST
$300$320$3403 Aug17 Aug31 Aug14 Sep28 Sep12 Oct26 Oct
Day’s Range
$330.20 - $340.19
52-Week Range
$244.82 - $377.54
Previous Close
$330.53
Volume
N/A
Average Volume (3M)
1.19M
Market Cap
$63.13B
Enterprise Value
$63.93B
Total Cash (Recent Filing)
$2.82B
Total Debt (Recent Filing)
$11.72B
Price to Earnings (P/E)
24.5
Beta
0.08
Next Earnings
Nov 04, 2026 (Est.)
EPS Estimate
4.58
Last Dividend Ex-Date
Aug 14, 2026
Dividend Yield
0.73%

Bulls Say, Bears Say

Bulls Say

Strong Cash Generation

Cencora’s substantial free cash flow provides recurring internal funding for debt service, reinvestment, acquisitions, and shareholder returns. The absolute cash generation improves financial resilience and gives management flexibility to support growth initiatives without relying entirely on external financing.

Specialty-driven Operating Growth

Specialty pharmaceuticals, oncology services, and related healthcare solutions are producing stronger growth and operating leverage than the underlying distribution model alone. This mix shift can support earnings durability by expanding higher-value services and deepening relationships with providers and manufacturers.

Expansion In Community Oncology

The AON transaction would broaden Cencora’s oncology platform, add access to more physician practices, and strengthen its integrated support model in community cancer care. Management expects the acquisition to be adjusted-EPS accretive in the second year, indicating a potentially durable strategic growth contribution.

Bears Say

Elevated Leverage

High leverage relative to equity leaves Cencora more sensitive to working-capital movements, financing costs, and execution setbacks. Although equity has rebuilt and cash flow is strong, the historical negative equity and elevated debt burden reduce flexibility for future acquisitions or an operating downturn.

Structurally Thin Margins

Cencora’s distribution-heavy model operates with limited margin protection, so modest pricing, volume, or product-mix pressure can materially affect earnings. Thin profitability constrains resilience and makes sustained operating improvement important for absorbing cost inflation, customer changes, or manufacturer economics.

Manufacturer Pricing Pressure

Large manufacturer price reductions can suppress reported revenue and challenge the economics of pharmaceutical distribution, particularly when the business earns relatively thin margins. Continued pricing actions could make growth harder to convert into profit and increase reliance on specialty mix and operating execution.

Cencora News

COR FAQ

What was Cencora’s price range in the past 12 months?
Cencora lowest stock price was $244.82 and its highest was $377.54 in the past 12 months.
What is Cencora’s market cap?
Cencora’s market cap is $63.13B.
When is Cencora’s upcoming earnings report date?
Cencora’s next earnings report is estimated for Nov 04, 2026 (not yet confirmed), which is in 1 day.
How were Cencora’s earnings last quarter?
Cencora released its earnings results on Aug 05, 2026. The company reported $4.48 earnings per share for the quarter, beating the consensus estimate of $4.347 by $0.133.
Is Cencora overvalued?
According to Wall Street analysts Cencora’s price is currently Undervalued.
Does Cencora pay dividends?
Cencora pays a Quarterly dividend of $0.6 which represents an annual dividend yield of 0.73%. See more information on Cencora dividends here
What is Cencora’s EPS estimate?
Cencora’s EPS estimate is 4.58.
How many shares outstanding does Cencora have?
Cencora has 190,827,160 shares outstanding.
What happened to Cencora’s price movement after its last earnings report?
Cencora reported an EPS of $4.48 in its last earnings report, beating expectations of $4.347. Following the earnings report the stock price went up 3.572%.
Which hedge fund is a major shareholder of Cencora?
Hedge funds hold Cencora shares: the largest hedge-fund position in Cencora is 71,887,433 shares, and hedge funds decreased their holdings by 1.7M shares last quarter.
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology